Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The cost of dengue fever challenges public health and national economies

07.07.2005


New study strengthens the case for development of vaccine to prevent mosquitoe-borne virus



A new study of the disease burden of dengue fever in Malaysia strengthens the case for development of a vaccine against the mosquito-borne illness.

Despite the nation’s efforts at treatment and control, 10,000 cases are reported each year at a l cost of almost $13 million, slightly less than half for vector control and the rest for treating hospitalized patients with dengue fever, an often painful and sometimes fatal virus.


These costs are equivalent to 940,000 lost workdays of output, said lead author Professor Donald Shepard, a health economist at Brandeis University’s Heller School for Social Policy and Management. In contrast, a prior study by Shepard and other researchers found that a dengue vaccine, if development proceeds as hoped, would offset 87 percent of treatment costs for all of Southeast Asia, as well as reduce the cost of vector control with fumigants and insecticides.

In effect, a vaccine made widely available would cost only marginally more than current treatment and control efforts, but with dramatic gains in public health and economic output.

"This study dramatically strengthens the case for developing and implementing an affordable vaccine wherever dengue is common," said Shepard. Although no vaccine is yet commercially available, several approaches are under development.

The first findings from this research, to be presented Thursday at the Symposium on National Health Accounts as part of the International Health Economics Association conference in Barcelona, Spain, evaluated the cost of treatment and control of dengue fever from 2000-2004 in Malaysia. Professor Lucy Lum of the University of Malaya and Dr. Jose Suaya of Brandeis co-authored the study.

"One hospitalized case of dengue fever costs one-fifth of Malaysia’s per capita gross national product (GNP)" noted Shepard. "The cost of treatment, the pain and suffering, the fear that a parent or child could die from this virus – all these facts are reasons why dengue is a salient candidate for vaccine development," Shepard said.

Currently, each person hospitalized with dengue fever or dengue hemorrhagic fever in Malaysia costs about $718 to treat. About 70 percent of the cost is paid for by the government, and the rest by insurers and individual households. This cost per patient is equivalent to 53 days of lost economic output, according to the study.

"Our study suggests just how devastating dengue is to economies and people, and by extension, how important it is to start thinking strategically about the most effective way to reduce the myriad costs of this illness," Shepard said. Dengue is endemic in much of Southeast Asia, Latin America and the Caribbean. Urban areas tend to be most affected because mosquitoes that transmit dengue live near people and breed in standing water found in discarded tires, old cans, flower pots, water tanks and other man-made containers.

In Southeast Asia dengue fever causes an estimated 27 million infections, 6 million illnesses, 400,000 hospitalizations and 3,000 deaths annually. In the Americas, 267,050 clinical cases and 71 deaths were reported in 2004, according to the Pan American Health Organization. Brazil reported the most cases in the region that year.

The study was sponsored by the Pediatric Dengue Vaccine Initiative, an organization created in 2002 to accelerate the development and use of a safe and effective dengue vaccine.

Brandeis University is currently managing dengue disease burden studies, which examine the economic burden of disease on households, governments and others, in nine countries: six in Latin America and three in Southeast Asia.

Laura Gardner | EurekAlert!
Further information:
http://www.brandeis.edu

More articles from Studies and Analyses:

nachricht Multi-year study finds 'hotspots' of ammonia over world's major agricultural areas
17.03.2017 | University of Maryland

nachricht Diabetes Drug May Improve Bone Fat-induced Defects of Fracture Healing
17.03.2017 | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>